Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail
Protein Sciences Corporation, Meriden, CT, United States
Search 21 grants from Gail Smith
Search grants from Protein Sciences Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Chemistry-Biology Interface Training Grant
Chemistry-Biology Interface Training Grant
Expression of genetically encoded photosensors in retinal bipolar neurons
Modulation of T-Type CA Channels
Motivic structures in physics
Recently added grants:
Chemoprotection and imaging for aminoglycoside and chemotherapy toxicities
The Mitochondria As Regulators Of Inflammation In Sepsis
The role of Nampt in age-associated persistent lung fibrosis
Catestatin improves glucose homeostasis and insulin sensitivity in diet-induced obese mice
Mitochondrial-Targeted Antioxidant-Encapsulating Nanoparticles as a Promising Therapeutic Strategy in Regulating Outflow Resistance
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI085333-002
Application #
2830748
Study Section
Project Start
1997-12-19
Project End
1998-12-18
Budget Start
1998-06-16
Budget End
1998-04-18
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Protein Sciences Corporation
Department
Type
DUNS #
City
Meriden
State
CT
Country
United States
Zip Code
06450
Related projects
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
Comments
Be the first to comment on this grant